Last reviewed · How we verify

Contrast-Enhanced Ultrasound using Lumason — Competitive Intelligence Brief

Contrast-Enhanced Ultrasound using Lumason (Contrast-Enhanced Ultrasound using Lumason) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Ultrasound contrast agent. Area: Diagnostic Imaging.

marketed Ultrasound contrast agent Diagnostic Imaging Small molecule Live · refreshed every 30 min

Target snapshot

Contrast-Enhanced Ultrasound using Lumason (Contrast-Enhanced Ultrasound using Lumason) — Children's Hospital of Philadelphia. Lumason is a microbubble contrast agent that enhances ultrasound imaging by reflecting sound waves, improving visualization of blood flow and tissue perfusion.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Contrast-Enhanced Ultrasound using Lumason TARGET Contrast-Enhanced Ultrasound using Lumason Children's Hospital of Philadelphia marketed Ultrasound contrast agent
Perflutren lipid Perflutren lipid UNC Lineberger Comprehensive Cancer Center marketed Ultrasound contrast agent
Definity infusion Definity infusion Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University marketed Ultrasound contrast agent
Optison echocardiography contrast agent Optison echocardiography contrast agent University of Utah marketed Ultrasound contrast agent
Contrast agent: SonoVue®. Contrast agent: SonoVue®. Centre Hospitalier Régional Metz-Thionville phase 3 Ultrasound contrast agent
SonoVue-enhanced ultrasound SonoVue-enhanced ultrasound Bracco Diagnostics, Inc phase 3 Ultrasound contrast agent
SonoVue® SonoVue® GE Healthcare phase 3 Ultrasound contrast agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Ultrasound contrast agent class)

  1. Second Affiliated Hospital, School of Medicine, Zhejiang University · 2 drugs in this class
  2. Bracco Diagnostics, Inc · 1 drug in this class
  3. Centre Hospitalier Régional Metz-Thionville · 1 drug in this class
  4. Children's Hospital of Philadelphia · 1 drug in this class
  5. GE Healthcare · 1 drug in this class
  6. Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · 1 drug in this class
  7. Sunnybrook Health Sciences Centre · 1 drug in this class
  8. UNC Lineberger Comprehensive Cancer Center · 1 drug in this class
  9. University of Utah · 1 drug in this class
  10. Acusphere · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Contrast-Enhanced Ultrasound using Lumason — Competitive Intelligence Brief. https://druglandscape.com/ci/contrast-enhanced-ultrasound-using-lumason. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: